Skip to main content

and
  1. Article

    Open Access

    Genetic and immunologic features of recurrent stage I lung adenocarcinoma

    Although surgery for early-stage lung cancer offers the best chance of cure, recurrence still occurs between 30 and 50% of the time. Why patients frequently recur after complete resection of early-stage lung c...

    Johannes R. Kratz, Jack Z. Li, Jessica Tsui, Jen C. Lee in Scientific Reports (2021)

  2. Article

    Open Access

    Systematic comparison of two whole-genome amplification methods for targeted next-generation sequencing using frozen and FFPE normal and cancer tissues

    Sequencing key cancer-driver genes using formalin-fixed, paraffin-embedded (FFPE) cancer tissues is becoming the standard for identifying the best treatment regimen. However, about 25% of all samples are rejec...

    Pedro Mendez, Li Tai Fang, David M. Jablons, Il-** Kim in Scientific Reports (2017)

  3. Article

    Open Access

    FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid

    Lung neuroendocrine (NE) tumors are a heterogeneous group of tumors arising from neuroendocrine cells that includes typical carcinoid, atypical carcinoid, small cell lung cancer (SCLC), and large cell NE cance...

    Hio Chung Kang, Jong In Kim, Hee Kyung Chang, Gavitt Woodard in Scientific Reports (2016)